You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carcinoma,non small cell lung

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic Response to Food in Advanced Lung Cancer

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Weight loss (%)
  • (no location specified)
Jun 30, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

NSCLC Trial (SGN-B6A, docetaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 21, 2023

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Self-administered survey at hospital
  • +2 more
  • (no location specified)
Oct 3, 2023

Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • BAI combine with DEB-BACE
  • Zhengzhou, Henan, China
    Gang Wu
Nov 7, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Wuhan, Hubei, China
      Qian Chu
    Aug 18, 2023

    NSCLC Trial (KB-GDT-01)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • KB-GDT-01
    • (no location specified)
    Sep 29, 2023

    Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Apr 21, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        QOL After SURGERY and ADJUVANT Treatment

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Quality of Life
        • Questionnaires
        • Salamanca, Spain
          Hospital Clínico Universitario
        Oct 30, 2023

        Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

        Recruiting
        • Carcinoma, Non-small-Cell Lung
        • New York, New York
        • +1 more
        Nov 8, 2023

        Stage IB Non-small Cell Lung Cancer

        Completed
        • Stage IB Non-Small Cell Lung Carcinoma
          • Shanghai, China
            180 Fenglin Road
          Jul 29, 2023

          NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • +2 more
          • Nintedanib, gefitinib, erlotinib, afatinib
          • (no location specified)
          Oct 2, 2023

          Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

          Not yet recruiting
          • Stage II-IIIB(N2) Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Oct 26, 2023

          Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

          Not yet recruiting
          • Colorectal Neoplasms
          • +5 more
          • (no location specified)
          Nov 9, 2023

          Double-dose Furmonertinib in Treatment of Slow

          Not yet recruiting
          • Non Small Cell Lung Cancer
          • +3 more
          • (no location specified)
          Oct 31, 2023

          NSCLC Trial in Chongqing (procedure, drug, radiation)

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • bronchial artery interventional therapy
          • +3 more
          • Chongqing, Chongqing, China
            Daping Hospital, Third Military Medical University
          May 27, 2023

          NSCLC Trial in Beijing

          Recruiting
          • NSCLC
            • Beijing, China
              Yuyan Wang
            Oct 10, 2023

            TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

            Not yet recruiting
            • Lung Cancer, Non-small Cell
            • Small Cell Lung Cancer
              • (no location specified)
              Nov 16, 2022

              Circulating Tumor DNA and T Cell Repertoire Predict

              Not yet recruiting
              • Carcinoma, Non-Small-Cell Lung
              • Brain Metastases
              • Whole-brain radiotherapy
              • Wuhan, Hubei, China
                Union hospital
              Feb 12, 2023

              Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

              Not yet recruiting
              • Metastatic Lung Non-Small Cell Carcinoma
              • +2 more
              • Cetuximab
              • +2 more
              • Sacramento, California
                University of California Davis Comprehensive Cancer Center
              Oct 2, 2023

              Integrative Multi-Omics Testing for Immunotherapy Response in

              Recruiting
              • Lung Cancer
                • Guangzhou, Guangdong, China
                  Nanfang hospital
                Jun 29, 2023

                NSCLC Trial in Shanghai

                Not yet recruiting
                • Non-small Cell Lung Cancer
                  • Shanghai, Shanghai, China
                    Shanghai Pulmonary Hospital
                  Jul 20, 2023